Abstract:Background: The ability to predict Alzheimers disease (AD) before diagnosis is a topic of intense research. Early diagnosis would aid in improving treatment and intervention options, however, there are no current methods that can accurately predict AD years in advance. This study examines a novel machine learning approach that integrates the combined effects of vascular (white matter hyperintensities, WMHs), and structural brain changes (gray matter, GM) with clinical factors (cognitive status) to predict post-mortem neuropathological outcomes. Methods: Healthy older adults, participants with mild cognitive impairment, and AD from the Alzheimer's Disease Neuroimaging Initiative dataset with both post-mortem neuropathology data and antemortem MRI and clinical data were included. Longitudinal data were analyzed across three intervals before death (post-mortem data): 0-4 years, 4-8 years, and 8-14 years. Additionally, cross-sectional data at the last visit or interval (within four years, 0-4 years) before death were also examined. Machine learning models including gradient boosting, bagging, support vector regression, and linear regression were implemented. These models were applied towards feature selection of the top seven MRI, clinical, and demographic data to identify the best performing set of variables that could predict postmortem neuropathology outcomes (i.e., neurofibrillary tangles, neuritic plaques, diffuse plaques, senile/amyloid plaques, and amyloid angiopathy). Results: A total of 94 participants (55-90 years of age) were included in the study. At last visit, the best-performing model included total and temporal lobe WMHs and achieved r=0.87(RMSE=0.62) during cross-validation for neuritic plaques. For longitudinal assessments across different intervals, the best-performing model included regional GM (i.e., hippocampus, amygdala, caudate) and frontal lobe WMH and achieved r=0.93(RMSE=0.59) during cross-validation for neurofibrillary tangles. For MRI and clinical predictors and clinical-only predictors, t-tests demonstrated significant differences at all intervals before death (t[-13.60-7.90], p-values<0.001). Overall, post-mortem neuropathology outcome were predicted up to 14 years before death with high accuracies (~90%). Conclusions: Prediction accuracy was higher for post-mortem neuropathology outcomes that included MRI (WMHs, GM) and clinical features compared to clinical-only features. These findings highlight that MRI features are critical to successfully predict AD-related pathology years in advance which will improve participant selection for clinical trials, treatments, and intervention options.

Prediction of Alzheimer's Disease Progression Based on Magnetic Resonance Imaging

Predictive Modeling Of Alzheimer's Disease Prognosis Using Anatomical & Diffusion MRI

Early prediction of Alzheimer’s disease using longitudinal volumetric MRI data from ADNI

A deep learning model for early prediction of Alzheimer's disease dementia based on hippocampal MRI

Use of multimodality imaging and artificial intelligence for diagnosis and prognosis of early stages of Alzheimer's disease

Automated Diagnosis and Prediction of Alzheimer Disease Using Magnetic Resonance Image.

Modeling disease progression via multi-task learning

Magnetic resonance imaging biomarkers for the early diagnosis of Alzheimer's disease: a machine learning approach

Prediction of Progressive Mild Cognitive Impairment by Multi-Modal Neuroimaging Biomarkers

Spatio-Temporal Similarity Measure based Multi-Task Learning for Predicting Alzheimer's Disease Progression using MRI Data

IMPROVED PREDICTION OF PROGRESSION TO CLINICAL STAGES OF ALZHEIMER’S DISEASE USING MULTIVARIATE SURFACE MORPHOMETRY OF MRI BIOMARKERS AND PATCH-BASED SPARSE CODING

Early-Stage Identification and Pathological Development of Alzheimer's Disease Using Multimodal MRI.

Exploring the power of MRI and clinical measures in predicting Alzheimers disease neuropathology

Investigating Predictors of Progression from Mild Cognitive Impairment to Alzheimer’s Disease Based on Different Time Intervals

Advances in MRI in diagnosis of early-stage Alzheimer’sdisease

Rethinking modeling Alzheimer's disease progression from a multi-task learning perspective with deep recurrent neural network

Exploring the Value of MRI Measurement of Hippocampal Volume for Predicting the Occurrence and Progression of Alzheimer's Disease Based on Artificial Intelligence Deep Learning Technology and Evidence-Based Medicine Meta-Analysis

Prediction of Alzheimer's Disease Progression with Multi-Information Generative Adversarial Network

Updated Models of Alzheimer's Disease with Deep Neural Networks

A Comprehensive Study on Early Alzheimer’s Disease Detection through Advanced Machine Learning Techniques on MRI Data

Deep Learning for Brain MRI Confirms Patterned Pathological Progression in Alzheimer's Disease